Patent US4185090A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4185090A Expired / Lapsed US ⏱️ 0.0 years remaining

Chemically modified endotoxin immunizing agent

Assignee: Abbott Laboratories
•
Filing: 1977-06-17
•
Granted: 1980-01-22
•
Expires: 1997-06-17
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A bacterial endotoxin lipopolysaccharide of reduced toxicity covalently coupled to a protein antigen exhibits enhanced adjuvant effects. The coupling was affected by reaction with haloacylhalide. Lipopolysaccharide acylated with an anhydride of a dibasic acid is detoxified; in combination with endotoxin polysaccharide covalently coupled to protein antigen it developed synergistic immunogenic effects.

Inventors

  • 👤 Floyd C. McIntire

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 15:16
CPC Classifications
A; A61; A61K; A61K39/00; A61K39/39; A61K39/385; C; C08; C08B; C08B37/00; A61K2039/555; A61K2039/55511; A61K2039/55572; A61K2039/60; A61K2039/6087; Y; Y10; Y10S; Y10S530/00; Y10S530/806

Claims Analysis

Total Claims: 10
Claim 1
Independent Claim 37 words
An ingredient for an immunizing agent comprising a protein antigen covalently coupled to a bacterial endotoxin partially detoxified lipopolysaccharide, said protein antigen having available --SH, imidazole or --NH 2 groups and said lipopolysaccharide having free amino groups.
Claim 2
Dependent Claim 37 words
An ingredient for an immunizing agent comprising a protein antigen covalently coupled to a bacterial endotoxin partially detoxified lipopolysaccharide, said protein antigen having available --SH, imidazole or --NH 2 groups and said lipopolysaccharide having free amino groups.
Claim 3
Dependent Claim 18 words
An ingredient for an immunizing agent comprising a protein antigen covalently coupled to a bacterial endotoxin haloacetylated polysaccharide.
Claim 4
Dependent Claim 18 words
An ingredient for an immunizing agent comprising a protein antigen covalently coupled to a bacterial endotoxin haloacetylated polysaccharide.
Claim 5
Independent Claim 109 words
The method of generating an immunologic response in a warm-blooded animal comprising administering to said animal a bacterial endotoxin lipopolysaccharide covalently coupled to a protein antigen in an amount sufficient to develop an antibody response in said animal, said lipopolysaccharide having at least one free amino group and an anhydride selected from the group consisting of compounds of the formula ##STR5## wherein n is 0 or 1, and R, R 1 and R 2 each represent hydrogen, C 1 -C 6 alkyl, C 2 -C 6 alkenyl, C 5 -C 6 cycloalkyl, phthalyl or methylphthalyl wherein any two R groups taken together form a saturated or unsaturated cyclic substituent.
Claim 6
Independent Claim 109 words
The method of generating an immunologic response in a warm-blooded animal comprising administering to said animal a bacterial endotoxin lipopolysaccharide covalently coupled to a protein antigen in an amount sufficient to develop an antibody response in said animal, said lipopolysaccharide having at least one free amino group and an anhydride selected from the group consisting of compounds of the formula ##STR5## wherein n is 0 or 1, and R, R 1 and R 2 each represent hydrogen, C 1 -C 6 alkyl, C 2 -C 6 alkenyl, C 5 -C 6 cycloalkyl, phthalyl or methylphthalyl wherein any two R groups taken together form a saturated or unsaturated cyclic substituent.
Claim 7
Independent Claim 45 words
The method of generating an immunologic response in a warm-blooded animal comprising administering to said animal a haloacylated bacterial endotoxin lipopolysaccharide and a haloacylated bacterial endotoxin polysaccharide covalently coupled to a protein antigen in an amount sufficient to develop an antibody response in said animal.
Claim 8
Independent Claim 45 words
The method of generating an immunologic response in a warm-blooded animal comprising administering to said animal a haloacylated bacterial endotoxin lipopolysaccharide and a haloacylated bacterial endotoxin polysaccharide covalently coupled to a protein antigen in an amount sufficient to develop an antibody response in said animal.
Claim 9
Dependent Claim 30 words
An immunizing agent in unit dosage form comprising a haloacylated bacterial endotoxin lipopolysaccharide and a haloacylated bacterial endotoxin polysaccharide covalently coupled to a protein antigen in an inert saline carrier.
Claim 10
Dependent Claim 30 words
An immunizing agent in unit dosage form comprising a haloacylated bacterial endotoxin lipopolysaccharide and a haloacylated bacterial endotoxin polysaccharide covalently coupled to a protein antigen in an inert saline carrier.

References Cited (Backward Citations)

US3600378A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1983-01-21 1983-07-23 1984-01-22 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1987-01-21 1987-07-23 1988-01-22 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1991-01-21 1991-07-23 1992-01-22 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag